Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter and fiscal year ended March 31, 2022
Filing Date: May 19, 2022
This filing serves as a disclosure of results of operations and financial condition. The company announced its financial results under International Financial Reporting Standards (IFRS) and Indian Accounting Standards (Ind AS) via a press release and attached exhibits.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached exhibits (Exhibits 99.1 through 99.4) and the company's website, which are referenced but not included in the text of this Form 6-K.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the announcement of results for the quarter and year ended March 31, 2022.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The text does not include specific management commentary, forward-looking guidance, or risk factors. It strictly references the attached press release and financial statements for these details.
Unusual Items: No unusual items are described in the filing text itself.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue and profit figures for Q4 and FY2022.
- Examine Exhibit 99.2 (IFRS Audited Consolidated Financial Results) for standardized international financial metrics.
- Check Exhibit 99.3 and 99.4 for Ind AS consolidated and standalone results to understand local regulatory reporting differences.
- Verify the company's website (www.drreddys.com) for the full text of the press release and detailed financial tables referenced in this filing.